FDA.reportPublic FDA data

Application 203183

Type
ANDA
Sponsor
FRESENIUS KABI USA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CISATRACURIUM BESYLATECISATRACURIUM BESYLATEINJECTABLE;INJECTIONEQ 2MG BASE/MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
63323-417CisatracuriumCISATRACURIUM BESYLATEFresenius Kabi USA, LLCANDACurrent
63323-417CisatracuriumCISATRACURIUM BESYLATEFresenius Kabi USA, LLCANDACurrent
63323-417CisatracuriumCISATRACURIUM BESYLATEFresenius Kabi USA, LLCANDACurrent
63323-417CisatracuriumCISATRACURIUM BESYLATEFresenius Kabi USA, LLCANDACurrent